Login

Create Account

AAOS 2025 Registration Is Now Open! Sign Up Early and Save.

We will be performing site maintenance on AAOS.org on November 26th from 8 - 9 AM CST, which may cause sitewide downtime. We apologize for the inconvenience.

AAOS Now, August 2021

FDA Ends Enforcement Discretion on Biologics and Regenerative Products

S. Raymond Golish, MD, PhD, MBA, FAAOS; Ryan Pezold, MA; David S. Jevsevar, MD, MBA, FAAOS

The FDA has formally ended the “enforcement discretion” of its comprehensive policy framework on biologics and regenerative medicine products.

AAOS Now, August 2021

FDA Ends Enforcement Discretion on Biologics and Regenerative Products